Alpha Tau Medical (DRTS) Current Assets (2020 - 2026)
Alpha Tau Medical's (DRTS) quarterly Current Assets came in at $81.3 million in Q1 2026, up 43.25% year-on-year from $56.8 million in Q1 2025, and up 3.9% quarter-over-quarter from $78.3 million in Q4 2025.
Alpha Tau Medical (DRTS) Current Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Current Assets across 7 years of filings, most recently posting $81.3 million for Q1 2026.
- Current Assets for Q1 2026 came in at $81.3 million, up 43.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.3 million (up 43.25% YoY), and the FY2025 annual result was $78.3 million, up 21.9% from the prior year.
- Current Assets came in at $81.3 million for Q1 2026 at Alpha Tau Medical, up from $78.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $111.2 billion in Q1 2022 to a low of $56.8 million in Q1 2025.
- The 5-year median for Current Assets is $85.8 million (2023), against an average of $6.6 billion.
- Across the five-year window, Current Assets surged 226.21% in 2022 and sank 99.91% in 2023, its largest moves.
- Alpha Tau Medical's Current Assets stood at $106.5 million in 2022, then fell by 19.46% to $85.8 million in 2023, then fell by 25.1% to $64.2 million in 2024, then gained by 21.9% to $78.3 million in 2025, then increased by 3.9% to $81.3 million in 2026.
- The last three Current Assets figures came in at $81.3 million (Q1 2026), $78.3 million (Q4 2025), and $77.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 600.85 Mn |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | 81.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.35 Mn |
| Dec 31, 2025 | 78.30 Mn |
| Sep 30, 2025 | 77.10 Mn |
| Jun 30, 2025 | 85.78 Mn |
| Mar 31, 2025 | 56.79 Mn |
| Dec 31, 2024 | 64.23 Mn |
| Sep 30, 2024 | 69.79 Mn |
| Jun 30, 2024 | 75.25 Mn |
| Mar 31, 2024 | 81.20 Mn |
| Dec 31, 2023 | 85.76 Mn |
| Sep 30, 2023 | 91.44 Mn |
| Jun 30, 2023 | 96.06 Mn |
| Mar 31, 2023 | 101.02 Mn |
| Dec 31, 2022 | 106.48 Mn |
| Sep 30, 2022 | 111.33 Mn |
| Jun 30, 2022 | 116.03 Mn |
| Mar 31, 2022 | 111.20 Bn |
| Dec 31, 2021 | 32.64 Mn |
| Dec 31, 2020 | 47.46 Mn |